Radient Technologies Inc. (V:RTI)
Business Focus: Alternative Medicine
| Sector: Healthcare | Industry: Pharmaceuticals |
| See Regulatory Filings on SEDAR | |
| Company Contact | |
| Address: | 8223 Roper Road EDMONTON AB T6E 6S4 |
| Tel: | N/A |
| Website: | www.radientinc.com |
| IR: | See website |
| Key People | ||
| Harry Kaura President, Chief Executive Officer, Director | Prakash Hariharan Chief Financial Officer | Steven Joseph Splinter Chief Technology Officer, Corporate Secretary, Director |
| Business Overview |
| Radient Technologies Inc. is a Canada-based manufacturer of cannabis derivatives, formulations and products. The Company's principal activities are research, development and commercialization of technology for the extraction, isolation and purification of soluble products from a range of materials using microwave technology. The Company is focused on the formulation, manufacturing and launching of cannabis products. It develops specialty products that contains a range of cannabinoid and terpene profiles. It also operates a scientific and product testing laboratory that offers solutions to the cannabis and wellness spaces. Its extraction platform extracts cannabinoids from cannabis and hemp biomass. Its cannabis formulations include tinctures, topicals, sub-lingual sprays, standardized oils, stable water soluble and water dispersible powders and solid powders. Its cannabinoid-based ingredients are formulated for use in food and beverage products, personal care products and others. |
| Financial Overview |
| For the nine months ended 31 December 2021, Radient Technologies Inc revenues increased 75% to C$3.4M. Net loss decreased 66% to C$6.8M. Revenues reflect Manufactured products increase of 80% to C$3.4M. Lower net loss reflects Impairment of inventories decrease from C$6.6M (expense) to C$0K, General and administrative decrease of 43% to C$2M (expense), Interest on short-term borrowings decrease of 65% to C$332K (expense). |
| Employees: | 33 as of Mar 31, 2020 |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $27.26M as of Dec 31, 2021 |
| Annual revenue (TTM): | $3.96M as of Dec 31, 2021 |
| EBITDA (TTM): | -$5.97M as of Dec 31, 2021 |
| Net annual income (TTM): | -$29.05M as of Dec 31, 2021 |
| Free cash flow (TTM): | -$1.08M as of Dec 31, 2021 |
| Net Debt Last Fiscal Year: | $12.07M as of Dec 31, 2021 |
| Shares outstanding: | 530,868,021 as of Feb 4, 2022 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
US Quotes Data provided by IEX. Company fundamental and price data sourced from © Refinitiv. Click for restrictions. © Refinitiv. All rights reserved. Republication or redistribution of Refinitiv, including by framing or similar means, is prohibited without the prior written consent of Refinitiv. Refinitiv is not liable for any errors or delays in Refinitiv content, or for any actions taken in reliance on such content.
Interactive technical study charts by TradingView. Copyright © 2022 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.